Meinertz, Thomas

Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease

Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 1,961

Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling

Mollnau, H., Wendt, M., Szöcs, K., Lassègue, B., Schulz, E., Oelze, M., Li, H., Bodenschatz, M., August, M., Kleschyov, A. L., et al. (2002) · Circulation Research

Nitric Oxide and Endothelin EffectsRenin-Angiotensin System Studies

Cited by 676

Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production

Skatchkov, M. P., Sperling, D., Hink, U., Mülsch, A., Harrison, D. G., Sindermann, I., Meinertz, T., & Münzel, T. (1999) · Biochemical and Biophysical Research Communications

Nitric Oxide and Endothelin EffectsNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 188

Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial

Goette, A., Schön, N., Kirchhof, P., Breithardt, G., Fetsch, T., Häusler, K. G., Klein, H. U., Steinbeck, G., Wegscheider, K., & Meinertz, T. (2012) · Circulation Arrhythmia and Electrophysiology

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Cited by 187

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

Kirchhof, P., Andresen, D., Bosch, R., Borggrefe, M., Meinertz, T., Parade, U., Ravens, U., Samol, A., Steinbeck, G., Treszl, A., et al. (2012) · The Lancet

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Cited by 176

Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry

for the ATRIUM investigators, Meinertz, T., Kirch, W., Rosin, L., Pittrow, D., Willich, S. N., & Kirchhof, P. (2011) · Clinical Research in Cardiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 91

Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy

Baldus, S., Müllerleile, K., Chumley, P., Steven, D., Rudolph, V., Lund, G. K., Staude, H.-J., Stork, A., Köster, R., Kähler, J., et al. (2006) · Free Radical Biology and Medicine

Gout, Hyperuricemia, Uric AcidCardiovascular Function and Risk Factors

Cited by 63

Diagnostic yield of external electrocardiographic loop recorders in patients with recurrent syncope and negative tilt table test

SCHUCHERT, A., MAAS, R., KRETZSCHMAR, C., BEHRENS, G., KRATZMANN, I., & MEINERTZ, T. (2003) · Pacing and Clinical Electrophysiology

Cardiovascular Syncope and Autonomic DisordersCardiac electrophysiology and arrhythmias

Cited by 62

Management of Patients With Atrial Fibrillation by Primary‐Care Physicians in Germany: 1‐Year Results of the ATRIUM Registry

Kirchhof, P., Schmalowsky, J., Pittrow, D., Rosin, L., Kirch, W., Wegscheider, K., Meinertz, T., & for the ATRIUM Study Group (2014) · Clinical Cardiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 37